您的位置：
首页
>
农业专利
>
详情页
RORGAMMA MODULATORS AND USES THEREOF
专利权人:
Genfit
发明人:
Jean-Francois Delhomel,Enrico Perspicace,Zouher Majd,Peggy Parroche,Robert Walczak,Pascal Bonnet,Jade Fogha
申请号：
US16481172
公开号：
US20190388414A1
申请日:
2018.01.29
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides novel compounds that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of RORgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, metabolic diseases, fibrotic diseases, or cholestatic diseases.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
RORgamma modulators and uses thereof
RORGAMMA MODULATORS AND USES THEREOF
antigen peptide or functional fragment thereof, pharmaceutical composition, methods for treating a neurodegenerative disease or disorder such as tauopathy, to induce an immune response in an animal, to diagnose a disease, disorder or condition and a predisposition to disease, disorder or condition, to monitor minimal residual disease in a patient and to predict a patient's receptivity, antibody, test kit, epitope, and cell line.
compounds, pharmaceutical composition and methods for the treatment of a neoplastic disease, for the treatment of an inflammatory or autoimmune disorder, for the treatment of a neurodegenerative disease and for the treatment of a metabolic disorder
Pharmaceutical composition with application for preparing medicine capable of treating memory disorder, Alzheimers disease, Parkinsons disease, psoriasis, heart diseases, and cancers for quickly increasing cAMP content and utilization ratio of drug
